Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

GlycoMimetics Inc (NASDAQ:GLYC)

5.66
Delayed Data
As of Mar 27
 +0.10 / +1.80%
Today’s Change
5.34
Today|||52-Week Range
9.25
-7.21%
Year-to-Date
No recent news for GlycoMimetics Inc.

Today’s Trading

Previous close5.56
Today’s open5.41
Day’s range5.41 - 5.69
Volume39,300
Average volume (3 months)41,992
Market cap$129.7M
Dividend yield--
Data as of 3:59pm ET, 03/27/2017

Growth & Valuation

Earnings growth (last year)-123.88%
Earnings growth (this year)+2.83%
Earnings growth (next 5 years)--
Revenue growth (last year)-99.91%
P/E ratioNM
Price/Sales7,008.84
Price/Book3.66

Competitors

 Today’s
change
Today’s
% change
MRTXMirati Therapeutics ...+0.05+0.97%
OPHTOphthotech Corp+0.12+3.40%
CNATConatus Pharmaceutic...+0.21+4.36%
DRRXDURECT Corp+0.01+0.72%
Data as of 3:59pm ET, 03/27/2017

Financials

Next reporting dateMay 11, 2017
EPS forecast (this quarter)-$0.36
Annual revenue (last year)$18.5K
Annual profit (last year)-$31.8M
Net profit margin-171,945.07%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Rachel K. King
Chief Financial Officer
Brian M. Hahn
Corporate headquarters
Rockville, Maryland

Forecasts


Search for Jobs